Title:
【発明の名称】ドーパミンD3受容体のモジュレーター(抗精神病薬)として有用なテトラヒドロベンズアゼピン誘導体
Document Type and Number:
Japanese Patent JP2002527433
Kind Code:
A
Abstract:
Compounds of Formula Iand their salts having affinity for dopamine receptors, in particular the D3 Receptor, and thus potential in the treatment of conditions wherein modulation of the D3 receptor is beneficial, e.g., as antipsychotic agents.
Inventors:
Michael Stuart Hadley
Christopher Nobert Johnson
Grego James McDonald
Jeffrey Stemp
Antonio Quoc Keon Bonn
Christopher Nobert Johnson
Grego James McDonald
Jeffrey Stemp
Antonio Quoc Keon Bonn
Application Number:
JP2000575857A
Publication Date:
August 27, 2002
Filing Date:
October 06, 1999
Export Citation:
Assignee:
SmithKline Beecham Public Limited Company
International Classes:
A61K31/55; A61P1/00; A61P1/08; A61P15/10; A61P25/14; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P25/32; A61P25/34; A61P25/36; A61P43/00; C07D223/16; C07D401/12; C07D401/14; C07D403/12; C07D405/12; C07D409/12; C07D413/12; C07D413/14; C07D417/12; C07D471/04; (IPC1-7): C07D223/16; A61K31/55; A61P1/00; A61P1/08; A61P15/10; A61P25/14; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P25/32; A61P25/34; A61P25/36; A61P43/00; C07D401/12; C07D401/14; C07D403/12; C07D405/12; C07D409/12; C07D413/12; C07D413/14; C07D417/12; C07D471/04
Attorney, Agent or Firm:
Aoyama Ryo (1 person outside)